Tactile Systems Technology AI Stock Analysis
Want to see TCMD full AI Analyst Report?
Tactile Systems Technology (TCMD) AI Stock Analysis
Tactile Systems Technology
(NASDAQ:TCMD)
The score is driven primarily by improved financial fundamentals (profitability turnaround, high gross margins, and a de-risked balance sheet) and supportive earnings guidance with raised adjusted EBITDA outlook. Technicals add a modest tailwind with improving near-term momentum, while valuation is a mild headwind given a 23.6 P/E and no dividend support. Airway-clearance weakness and some margin/cash-conversion softening temper the otherwise solid setup.
Tactile Systems Technology Key Performance Indicators (KPIs)
Revenue by ChannelShows how sales split across distribution routes—such as direct sales, distributors, clinics or online—revealing which channels drive growth, which are most scalable or profitable, and where the company is vulnerable to concentration or partner risk. Trending shifts between channels also indicate how well management can expand reach or control pricing and margins.
Lymphedema is the durable growth engine—revenues across private payers and Medicare have trended higher and underpin management’s upgraded guidance—while airway‑clearance (DME) revenue is noisier and hit by temporary inventory management and Medicare prior‑authorization timing. The near‑term softness in the DME channel explains quarter‑to‑quarter volatility, but strong trailing‑12‑month AffloVest growth, next‑gen product rollout and new distribution deals point to normalization later in the year; channel concentration remains a risk until orders and DME inventory dynamics stabilize.
Tactile Systems Technology (TCMD) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $590.72M
- Dividend Yield
- ―
- Average Volume (3M)
- 260.47K
- Price to Earnings (P/E)
- 25.1
- Beta (1Y)
- 0.64
- Revenue Growth
- 14.41%
- EPS Growth
- 34.35%
- Country
- US
- Employees
- 1,086
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Tactile Systems Technology Business Overview & Revenue Model
Company Description
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compressi...
How the Company Makes Money
Tactile Systems Technology primarily makes money by selling pneumatic compression therapy systems (e.g., Flexitouch) and related consumable and replacement items such as garments, wraps, and accessories used with its devices. Revenue is generally gen...
Tactile Systems Technology Earnings Call Summary
The call was predominantly positive, supported by sustained 13% lymphedema growth, broad commercial and Medicare gains, improved gross margin, strong cash generation, maintained revenue guidance and higher adjusted EBITDA guidance. The main challenges were the 25.1% airway-clearance revenue decline, the reduced airway-clearance outlook, lower quarterly operating income and net income, adjusted EBITDA margin compression, and the continued time required to improve referral conversion, payer coverage and new-product commercialization.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
The company is maintaining full year 2026 revenue guidance of $360 million to $366 million, representing growth of approximately 9% to 11% year-over-year, and raising adjusted EBITDA guidance to $50 million to $52 million, representing growth of approximately 12% to 16% compared with $44.8 million in 2025; it expects low double-digit growth in lymphedema, full year airway clearance revenue to decline in the mid- to high single digits, meaningful sequential growth in lymphedema in the fourth quarter with a moderation in year-over-year growth, and sequential improvement in fourth-quarter airway clearance revenue with revenue remaining below the prior year. Full year modeling assumptions are GAAP gross margin of approximately 76.5%, GAAP operating expense growth of 10% to 12%, net interest income of approximately $2.4 million, an effective tax rate of approximately 28% and fully diluted weighted average shares outstanding of approximately 23 million, with adjustments of stock-based compensation expense of approximately $8.6 million, depreciation and amortization expense of approximately $7.3 million, executive transition costs of approximately $1.3 million, acquisition-related and integration costs of approximately $1.3 million and litigation-related costs of approximately $1 million.
Tactile Systems Technology Financial Statement Overview
Summary
Multi-year turnaround with sustained profitability since 2023, consistently high gross margins (~71–75%), and meaningful revenue growth. Balance sheet is a clear strength with very low leverage (debt-to-equity ~0.07–0.08) and improving ROE. Key watch items are modest TTM operating margin softening (EBIT margin ~7.3% vs ~8.7–9.8% in 2024–2025) and weaker TTM operating cash flow coverage (~0.68) despite still-positive free cash flow.
Income Statement
78PositiveBalance Sheet
86Very PositiveCash Flow
70Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 356.42M | 329.52M | 292.98M | 274.42M | 246.78M | 208.06M |
| Gross Profit | 264.89M | 247.70M | 216.69M | 195.13M | 175.98M | 148.21M |
| EBITDA | 42.47M | 39.02M | 32.37M | 26.42M | -6.42M | 1.41M |
| Net Income | 23.82M | 19.09M | 16.96M | 28.52M | -17.87M | -11.81M |
Balance Sheet | ||||||
| Total Assets | 291.29M | 273.94M | 297.92M | 281.44M | 255.00M | 244.27M |
| Cash, Cash Equivalents and Short-Term Investments | 75.11M | 83.45M | 108.91M | 75.23M | 38.06M | 40.71M |
| Total Debt | 17.07M | 15.96M | 45.11M | 50.38M | 72.23M | 80.61M |
| Total Liabilities | 64.04M | 55.04M | 81.33M | 87.80M | 133.60M | 116.04M |
| Stockholders Equity | 227.25M | 218.90M | 216.60M | 193.64M | 121.40M | 128.23M |
Cash Flow | ||||||
| Free Cash Flow | 28.96M | 40.43M | 38.15M | 33.37M | 3.29M | 276.00K |
| Operating Cash Flow | 32.19M | 42.81M | 40.66M | 35.85M | 5.21M | 2.63M |
| Investing Cash Flow | -12.56M | -2.54M | -2.50M | -2.48M | -1.91M | -82.18M |
| Financing Cash Flow | -10.49M | -51.20M | -4.82M | 5.73M | -9.60M | 59.93M |
Tactile Systems Technology Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TCMD, the sentiment is Positive. The current price of 26.37 is above the 20-day moving average (MA) of 24.98, above the 50-day MA of 23.45, and above the 200-day MA of 25.68, indicating a bullish trend. The MACD of 1.02 indicates Negative momentum. The RSI at 61.17 is Neutral, neither overbought nor oversold. The STOCH value of 59.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TCMD.
Tactile Systems Technology Risk Analysis
Tactile Systems Technology disclosed 74 risk factors in its most recent earnings report. Tactile Systems Technology reported the most risks in the "Tech & Innovation" category.
Latest Risks Added
3 New RisksTactile Systems Technology Peers Comparison
Overall Rating
ELMD76Outperform
TCMD75Outperform
INFU70Outperform
ENOV58Neutral
MYO51Neutral
AHCO49Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | $188.82M | 15.98 | 23.73% | ― | 14.12% | 47.72% | |
| 75Outperform | $590.72M | 25.07 | 10.73% | ― | 14.41% | 34.35% | |
| 70Outperform | $296.30M | 31.31 | 15.77% | ― | 2.40% | 76.01% | |
| 58Neutral | $1.61B | -2.98 | -35.53% | ― | 3.28% | 62.02% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 51Neutral | $40.90M | -2.98 | -208.07% | ― | 9.27% | -22.32% | |
| 49Neutral | $1.06B | -2.59 | -28.90% | ― | -3.17% | -636.28% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TCMD | Tactile Systems Technology | 26.37 | 3.18 | 13.71% | |
| ENOV | Enovis Corporation | 27.92 | -0.32 | -1.13% | |
| ELMD | Electromed | 23.10 | -1.42 | -5.79% | |
| INFU | InfuSystem Holdings, Inc. | 14.79 | 5.48 | 58.86% | |
| MYO | Myomo Inc | 1.02 | 0.30 | 41.67% | |
| AHCO | Adapthealth | 7.73 | -1.37 | -15.05% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 04, 2026
